研究目的
Assessment of the photodynamic therapy with the use of a superluminescent light-emitting diode lamp after previous application of 5-aminolevulinic acid based on the observations of selected cases of patients with actinic keratosis.
研究成果
Observation results indicate a beneficial effect of superluminescent light-emitting diodes and no recurrence of actinic keratosis lesions in 3 months after the procedure.
研究不足
The study presents only three selected cases of patients treated with photodynamic therapy with the use of superluminescent light-emitting diode lamp, which may not represent all possible outcomes of the treatment.
1:Experimental Design and Method Selection:
The study included patients diagnosed with actinic keratosis. After debridement of scales and crusts from the affected skin area, 16% 5-aminolevulinic acid cream was applied. The irradiation was performed with the use of the superluminescent light-emitting diode matrix illuminator Medlight that sent out pulsed red light.
2:Sample Selection and Data Sources:
Patients diagnosed with actinic keratosis were selected.
3:List of Experimental Equipment and Materials:
A preparation containing 16% 5-aminolevulinic acid (ALA) cream, Hascobaza, and the superluminescent light-emitting diode matrix illuminator Medlight were used.
4:Experimental Procedures and Operational Workflow:
After debridement of scales and crusts from the affected skin area, the ALA cream was applied and covered with an occlusive dressing for 3 hours. Then, cream debris were removed with a gauze pad soaked with a
5:9% sodium chloride solution. The irradiation was performed with the use of the superluminescent light-emitting diode matrix illuminator Medlight. Data Analysis Methods:
The clinical evaluation was carried out before, immediately after the procedure as well as after 1 and 3 weeks.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容